OBJECTIVE: Opioid use, addiction, and overdose are a growing epidemic in the United States. According to the Centers for Disease Control and Prevention, fatalities from prescription opioids, such as oxycodone, hydrocodone, and morphine, have quadrupled in recent years. It is believed that overprescribing of opioids has contributed to the issue. The objective of this study was to determine if the amount of opioids prescribed in the postoperative period for gynecologic and pelvic reconstructive surgeries was insufficient, adequate, or in excess. MATERIALS AND METHODS: This study was deemed exempt from human subjects research review by the institutional review board as it was a quality improvement project. Data was collected prospectively. All patients who were at least 18 years old and underwent gynecologic and/or pelvic reconstructive surgeries in our practice from April through August 2016 were eligible to participate. Participants were categorized into mutually-exclusive groups based on their primary procedure. Participants who underwent more than one procedure were placed into the procedure group considered to be the most invasive. We considered abdominal laparotomy to be the most invasive, followed by laparoscopic/robotic surgery, vaginal surgery, mid-urethral sling, sacral neuromodulation and other minor procedures. Routine practice is to prescribe 30 tablets of opioids for major procedures and 10-15 tablets for minor procedures for postoperative pain management. At the two-week postoperative visit, participants completed a questionnaire that asked about the number of tablets they were prescribed and used, their postoperative pain control experience, and relevant medical history. Fisher's exact test was used to compare data. RESULTS: Sixty-five participants completed questionnaires; 8 (12.3%) were excluded from the analysis as they did not receive opioids. Half (49.1%) of participants reported being prescribed more opioids than needed, while 2 (3.5%) felt the amount was less than what they needed. Though not significant, patients who underwent major surgeries were more likely to report being prescribed more opioids than needed (53.5%) compared with patients who underwent minor surgeries (35.7%; p¼0.47). Nineteen (33.3%) patients had a history of anxiety, 12 (21.4%) a history of chronic pain, 17 (30.4%) a history of depression, and 1 (1.8%) reported current use of recreational drugs. Though not statistically significant, participants with a history of anxiety were less likely to report having been prescribed more tablets than needed compared to patients without a history of anxiety (44.4% vs. 57.1%; p¼0.38) . This was also true of patients with a history of depression compared to those without a history of depression (37.5% vs. 58.3%); p¼0.17), and those with a history of chronic pain compared to those without a history of chronic pain (33.3% vs. 60.0%; p¼0.10). CONCLUSIONS: Our current opioid prescription practice for postoperative pain management may exceed what patients need.
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